Bell Palsy: Facts and Current Research Perspectives.
Rajangam J, Lakshmanan AP, Rao KU, Jayashree D, Radhakrishnan R, Roshitha B, Sivanandy P, Sravani MJ, Pravalika KH.
CNS Neurol Disord Drug Targets. 2024;23(2):203-214. doi: 10.2174/1871527322666230321120618.
Diplopia Rhinoceros.
Teja BSS, Balineni A, Sri IL, Mulpuri KS, Ganti E.
Ann Afr Med. 2025 Oct 1;24(4):949-953. doi: 10.4103/aam.aam_14_25. Epub 2025 Apr 1.
Impact of GLP-1 receptor agonists on cranial nerve palsies in type 2 diabetes: a retrospective cohort study.
Bhatia R, Al-Bana H, Mohamed K, Amaefuna C, Johnson S, Munasinghe B, Elkomi R, Gillani SF, Beyene E, Bisrat M, Michael M.
J Neurol. 2025 Dec 8;273(1):16. doi: 10.1007/s00415-025-13560-9.
Oculomotor palsy in diabetics.
Lajmi H, Hmaied W, Ben Jalel W, Chelly Z, Ben Yakhlef A, Ben Zineb F, El Fekih L.
J Fr Ophtalmol. 2018 Jan;41(1):45-49. doi: 10.1016/j.jfo.2017.06.010. Epub 2017 Dec 28.
Botulinum toxin A in the early treatment of sixth nerve palsy in type 2 diabetes.
Ganesh S, Anilkumar SE, Narendran K.
Indian J Ophthalmol. 2019 Jul;67(7):1133-1136. doi: 10.4103/ijo.IJO_1267_18.
Risk of ischemic stroke after third, fourth, and sixth cranial nerve palsies in type 2 diabetes.
Park SJ, Yang HK, Byun SJ, Park KH, Hwang JM.
J Diabetes. 2019 May;11(5):379-385. doi: 10.1111/1753-0407.12859. Epub 2018 Nov 15.
Challenges of Pituitary Apoplexy in Pregnancy.
Gheorghe AM, Trandafir AI, Stanciu M, Popa FL, Nistor C, Carsote M.
J Clin Med. 2023 May 11;12(10):3416. doi: 10.3390/jcm12103416.
[Cranial mononeuropathy in patients with diabetes mellitus].
Parhofer K.
MMW Fortschr Med. 2020 Apr;162(8):46-47. doi: 10.1007/s15006-020-0429-4.
Multiple cranial nerve palsies associated with type 2 diabetes mellitus.
Singh NP, Garg S, Kumar S, Gulati S.
Singapore Med J. 2006 Aug;47(8):712-5.
Nothnagel Syndrome Without Extremity Symptoms: A Case Report.
Zanella GS, Brooks B, Lui F.
Cureus. 2024 Nov 24;16(11):e74346. doi: 10.7759/cureus.74346. eCollection 2024 Nov.
